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ABSTRACT: Tools that allow cost-effective screening of the
susceptibility of cell lines to operating conditions which may apply
during full scale processing are central to the rapid development of
robust processes for cell-based therapies. In this paper, an ultra scale-
down (USD) device has been developed for the characterization of the
response of a human cell line to membrane-based processing, using just
a small quantity of cells that is often all that is available at the early
discovery stage. The cell line used to develop the measurements was a
clinically relevant human ﬁbroblast cell line. The impact was evaluated
by cell damage on completion of membrane processing as assessed by
trypan blue exclusion and release of intracellular lactate dehydrogenase
(LDH). Similar insight was gained from both methods and this allowed
the extension of the use of the LDH measurements to examine cell
damage as it occurs during processing by a combination of LDH
appearance in the permeate andmass balancing of the overall operation.
Transmission of LDHwas investigatedwith time of operation and for the
two disc speeds investigated (6,000 and 10,000 rpm or emax 1.9 and
13.5WmL1, respectively). As expected, increased energy dissipation
rate led to increased transmission as well as signiﬁcant increases in rate
and extent of cell damage. Themethod developed can be used to test the
impact of varying operating conditions and cell lines on cell damage and
morphological changes.
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Introduction
The cell-based therapy industry is rapidly growing and becoming
increasingly important, having led to the emergence of several new
products approved for clinical use and many more currently in
clinical trials (Coopman andMedcalf, 2014). In the past two decades,
the industry has seen the approval and commercialization of the ﬁrst
cell-based therapies (Brandenberger et al., 2011). Yet, a number of
challenges remain in getting new therapies to market. The
production and subsequent bioprocessing of the cells is of utmost
importance, as the product and process have become inseparable
(Mason andHoare, 2006). This is primarily because the end-products
are deﬁned by their respective manufacturing process.
The exposure to a range of mechanical and physicochemical
stresses during processing can cause internal adjustments in the cell.
These adjustments can lead to physiological and metabolic changes
(Acosta-Martinez et al., 2010; Al-Rubeai et al., 1995b; Zoro et al.,
2008), complete lysis or programmed cell death (Mollet et al., 2007)
and physical changes that can cause mechanical damage (Acosta-
Martinez et al., 2010; Mardikar and Niranjan, 2000; McCoy et al.,
2009, 2010). Therefore, a major challenge to successful commercial-
izing of cell-based therapies depends on the development of scalable
manufacturing processes while maintaining potency, purity, and
viability of the ﬁnal live cell product (Carmen et al., 2012).
Most manufacturing processes include a clariﬁcation and
concentration step of the cellular material derived from cell culture.
Typically, a centrifugation or a ﬁltration step is included to remove
large aggregates, unwanted proteins, cell debris, and to concentrate
the cellular suspension (Pattasseril et al., 2013). Cell-based
therapies to date use batch dead-end centrifugation for cell
concentration. However, centrifugation has proven to be a difﬁcult
step to automate while maintaining sterility (Mason and Hoare,
2006) as it requires the use of biological safety cabinets for the
transfer stages. Therefore, if these therapies are to be commercial-
ized at an industrial scale, batch centrifugation can signify a
problem to achieve the required cell numbers for the manufacture
of whole cell therapies (Lapinskas, 2010). Other alternatives such as
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continuous counterﬂow centrifugation and tangential ﬂow ﬁltration
may be more amenable to large-scale, contained and automated
operations (Pattasseril et al., 2013). Counterﬂow centrifugation
systems—like kSep1 (KBI Biopharma) and Elutra cell separation
system (Terumo BCT)—can wash cells, clear residuals from the
supernatant and buffer exchange, while keeping the cells in
suspension. kSep1 in particular can be fully automated and
contained, uses a disposable ﬂow path processing 0.1 to thousands
of liters, while achieving high cell recoveries (>80%) and high cell
viabilities (>90%). The capital investment needed, coupled with
the cost of disposables, needs consideration in process development
(Pattasseril et al., 2013). Tangential ﬂow ﬁltration offers an
alternative that can be scaled, automated, fully contained and,
generally, with a lower capital investment and disposables costs,
amenable to process development (Pattasseril et al., 2013).
Process development starts with the preparation of highly
characterized cells using bench-scale technologies and the focus of
scale-up is to reproduce this quality when preparing the cells at scale
(Carmen et al., 2012). The development of bench-scale technologies
which better mimic the full scale would help signiﬁcantly with this
translation. A series of ultra scale-down (USD) tools have been
created to mimic various large scale operations such as continuous
centrifugation (Boychyn et al., 2001; Hutchinson et al., 2006) and
depth ﬁltration (Jackson et al., 2006; Lau et al., 2013). USD devices
allow the investigation of several manufacturing hydrodynamic
environments (McCoy et al., 2009, 2010; Zoro et al., 2009) and
geometries (Acosta-Martinez et al., 2010) with little material,
signiﬁcantly increasing the throughput of the experimental phase in a
cost-effective and time-efﬁcient manner.
In this study, a modiﬁed version of the membrane separation
USD device designed by Ma et al. (2010) was used to develop a
methodology to investigate the effect of membrane processing on
recovery of cells for therapy. The novelty lies in the use of mass
balances across the membrane for the non-invasive analysis of cell
rupture as recorded by release of cytosolic lactate dehydrogenase
(LDH) to give a rate of cell damage. The exclusion of trypan blue dye
and the release of cytosolic LDH enzyme was used to characterize
the ﬁnal extent of cell damage in terms of loss of cell wall integrity
(noted as loss of viability in this paper).
Materials and Methods
Cell Preparation
A human neonatal foreskin ﬁbroblast cell line (HCA2 cells, provided
by Prof David Kipling, University of Cardiff, UK) was cultured from
frozen stock (passage 11) to 70–80% conﬂuency (T175 ﬂasks,
Greiner Bio-One, Frickenhausen, Germany) in Dulbecco’s Modiﬁed
Eagles Medium (DMEM, Invitrogen, Paisley, UK), supplemented
with 10% (v/v) foetal calf serum (PAA Laboratories, Linz, Austria)
and 2mM of glutamine (Invitrogen). The supplemented medium
will be referred as complete growth medium (hCGM). The cells were
taken to a maximum of passage 25 over 60 days. For cell harvesting,
the spent medium was removed; the cells were rinsed once with
Dulbecco’s Phosphate Buffered Saline (DPBS) (Sigma–Aldrich,
Ayrshire, UK) and enzymatically detached using 5mL of TrypLETM
Select (Invitrogen) for 5min at 37C. To quench the enzyme, an
equal volume of growth media was introduced into the ﬂask and the
cells were centrifuged (Thermo, Strasbourg, France) for 3 min at
500 g and room temperature (21 1C). The cells were
subsequently resuspended in 10mL of growth medium to yield
a suspension of 2 106 cells mL1and used within 5min for
membrane separation studies.
Membrane Separation Studies
The membrane separation device used (see Fig. 1A) is similar to
that described by Ma et al. (2010) and was built by the UCL Rapid
Design and Fabrication Facility. It consisted of a centrally mounted
conical disc, 15mm diameter with a 4 conical cross-section, with
an accompanying shaft assembly fabricated from stainless steel. It
is housed in a sealed Perspex chamber of internal diameter of
21mm and a ﬁxed total volume of 1.7 mL (Fig. 1A). A 25mm
diameter polyvinylidene ﬂuoride Durapore1membrane (Millipore,
Hertfordshire, UK) with 0.65mm pore size, was mounted between
the bottom of the shear cell and an O-ring seal of 25 mm outer
diameter that sits on the permeate port (Fig. 1A). Due to the width
of the O-ring, the effective area of the membrane is 3.64 cm2. A high
speed motor with a feedback loop (Outrunner Motor, 920Kv Park
400, Champaign, Illinois) was used to give disc rotational speeds of
6,000 50 and 10,000 100 rpm. The chamber is ﬁtted with a
pressure sensor (RS Components Ltd, Northants, UK) connected to
a multifunction data acquisition device (National Instruments
Corporation Ltd, Berkshire, UK).
Computational ﬂuid dynamics (CFD) software (Comsol Multi-
pysics 3.4, Comsol, Hatﬁeld, UK) was used to analyze the mean and
maximum shear forces in the USD membrane separation chamber
using methods described by Ma et al. (2010) for the establishment
of mesh size and convergence. Figure 1B shows in a three-
dimensional heat map how the magnitude of the ﬂuid velocity
experienced by the material present in the retentate chamber varies
with spatial location (assuming a density of water of 0.99 g cm3 at
21 1C). It is evident that therefore the highest shear experienced
is at the edges of the rotating disc (red areas which denote highest
ﬂuid velocity in Fig. 1B). The areas on top and below the rotating
disc located away from the edges, exhibit a more even distribution
of shear rates experienced by the ﬂuid. For turbulent ﬂow, the shear
rate (g) can be translated to energy dissipation rate (e PW/V),
which will be the parameter used in this paper, using the following
relationship (Harrison et al., 2015):
g ¼ PW=V
ry
 1=2
ð1Þ
where PW is the power (W), r is the density of the ﬂuid (assumed to
be 1 103 kg m3) and y is the kinematic viscosity of the ﬂuid
(assumed to be 1 106 m2 s1). Local energy dissipation rates
can be10 times higher than the average rate and these probably
determine cell damage, the focus of this paper. At 6,000 rpm disc
speed, the average over the membrane surface and local (maximum
at disc tip) energy dissipation rates are 0.2 and 1.9WmL1,
respectively, (average and maximum shear rates of 14,000 and
44,000 s1). At 10,000 rpm disc speed, local, and maximum energy
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dissipation rates equate to 1.4 and 13.5WmL1 (average and
maximum shear rates of 37,000 and 116,000 s1). Energy
dissipation rate values quoted hereafter will be maximum energy
dissipation rates (emax). The shear rates used here are considerably
higher than reported in literature, 3,000 s1 (Cunha et al., 2015)
and 4,000 s1 (Rowley et al., 2012). This is to ensure that cell
damage is recorded with a view to identifying conditions where no
damage might occur, that is, to verify observations at full scale.
Cells were loaded using a disposable syringe, ensuring no air
remaining in the chamber. The device was sealed and the cellular
Figure 1. (A) An expanded view of the ultra scale-down membrane filtration device (in this study the port located opposite that for sampling is used as the feed port), (B)
computational fluid dynamic (CFD) simulation displaying the fluid velocity experienced at various locations of the USD membrane device at 10,000 rpm. Simulation assumes viscosity
of 1 mPa s.
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material was then sheared for 60min at room temperature
(21 1C). A 100mL disposable syringe driven by a syringe pump
(PHD 4400, Harvard Apparatus Ltd, Kent, UK) was used to feed
growth media at a rate of 0.5 mLmin1 (equivalent ﬂux rate of 82
LMH). The permeate was collected at 5min intervals for 60min.
The chamber contents were collected at the end of the operation. A
non-sheared control was held in an Eppendorf tube concurrently, at
the same temperature, for the duration of the experiment.
Cell Suspension Analysis
Membrane integrity and concentration measurements were carried
out, in quadruplicate, using the trypan blue exclusion method
carried out in an automated,time-controlled, haemocytometer (Vi-
Cell XRTM, Beckman Coulter, Fullerton, CA). The device takes ﬁfty
images per sample and cell counting and analysis is carried out by
using video imaging through a quartz ﬂow cell. Membrane integrity
(or percentage viability) is a measure of the proportion of viable
cells to total cells as recorded by trypan blue exclusion.
Cell Damage
LDH is a stable cytosolic enzyme that is released upon cell lysis.
LDH was measured using a colorimetric assay (CytoTox-961 Non-
Radioactive Cytotoxicity Assay, Promega UK, Southampton, UK)
that quantitatively measures LDH released in the supernatant by
using a 30min coupled enzymatic assay which converts a
tetrazolium salt (INT) into red formazan product.
The sample collected for LDH analysis was aliquoted into eight
wells of a 96-well round-bottom plate (Nalgene Nunc Interna-
tional, New York), each containing 10,000–20,000 cells to obtain a
reliable signal. A total of 10mL of lysis solution (9% (v/v)
Triton1 X-100) was added to four wells (technical repeats) for
each sample, in order to measure the “total LDH release”
(“LDHTOT” i.e., maximum release which includes extracellular or
soluble LDH released to the medium as well as LDH from intact
cells in the sample). A total of 10mL of growth medium was
added to the remaining four wells, to correct for volume. These
wells were used to measure the “extracellular LDH release”
(“LDHEXT” i.e., release from non-viable and already lysed cells).
“Intracellular LDH” (“LDHINT” i.e., LDH contained in viable cells
with intact membranes) was calculated by the difference between
the total and extracellular measurements.
The samples analyzed were: (i) the feed at time 0 (F, pre-
processing); (ii) the retentate at 60min (PP, post-processing); and
(iii) the non-sheared control (C) also measured at time 60min.
Mass Balances
Figure 2 shows the block diagram for the experimental set-up used
to derive the amount of soluble LDH present during each time
interval (Dti). From left to right, a feed (growth media), F, is
supplied to the USDmembrane separation device at a constant ﬂow
rate, Q, by a syringe pump ﬂushing growth media at a constant ﬂux
of 82 LMH for 60min. The ﬂux of choice and time of operation are
in accordance with recent ﬁndings for larger scale (up to 2 L) TFF
platform used by Cunha et al. (2015). The authors have shown for
human mesenchymal stem cells (hMSCs), high cell recovery
(>80%) and high percentage viability (>90%) post-processing
when controlling the permeate ﬂux at 60, 120, and 250 LMH (time
of operation of 92, 44, and 22min, respectively).
For this study, the permeate stream, P, exiting the USD
membrane separation device (labeled “Block USD device”) is
pooled over 5-min intervals, where “i” denotes the interval number,
Figure 2. Block diagram for the experimental set-up used to derive the amount of soluble LDH present during each time interval (Dtn). The terms shown in (a) to (d), define the
amount of LDH at various time points and locations in the experimental set-up. (a) Initial soluble LDH, mU; (b) soluble LDH for non-sheared control, mU; (c) soluble LDH remaining in
retentate at end of study, mU; and (d) total LDH released and transmitted through membrane, mU.
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i¼ 1–12. The average concentration of extracellular LDH present in
the retentate for any given time interval, Dti, is estimated using:
R½ LDHEXT Dtið Þ ¼
P½ LDH Dtið Þ
T tð Þ ð2Þ
where [P]LDH(Dti) is the measured concentration of LDH present in
the permeate collected over interval Dti, subscript “LDHEXT” refers
to extracellular component and T(t) is the LDH transmission at
time t. Even though a 0.65mm membrane is used, transmission
values of<100% for LDH might be expected due the high
concentrations of proteins present which will interact with the
membrane. The transmission value, T(t), for 6,000 rpm was
measured every 15min intervals for 60min as shown in Figure 3.
An average transmission coefﬁcient of 0.80 was recorded for T(tf)
values ranging from 15 to 60min with no signiﬁcant trend noted
with varying time. It was, therefore, concluded, that for both 6,000
and 10,000 rpm, a constant value of transmission may be assumed
throughout the run to correct for the measured average
concentration of LDH in the permeate over any particular
time interval, and that value can be measured at the end of the
run, t¼ tf:
T tf
  ¼ P½ LDH tf
 
R½ LDH EXT tf
  ð3Þ
where tf is the ﬁnal minute of processing, [P]LDH(tf) is the
concentration of extracellular LDH present in the permeate
collected over the period tf 1min to tf and [R]LDHEXT(tf) is the
measured concentration of extracellular LDH in the retentate.
The experimental results for the LDH data for any of the runs, at
any of the two given disc speeds, provides considerable information
about the system. It informs on the concentrations of soluble LDH
in the permeate and in the retentante over the ﬁnal minute of
operation (tf). These values are then used to calculate the
transmission coefﬁcient speciﬁc for that run. As shown in Figure 4,
with the exception of one outlier at high disc speed, the
reproducibility from one repeat to another is high, giving
conﬁdence in this measurement. It can, therefore, be concluded
that average transmission values calculated at 6,000 and 10,000 rpm
of 0.78 0.02 and 0.84 0.06, respectively, are representative of
the individual repeats.
Other experimental data collected by LDH analysis also gives the
following parameters over 5-min intervals from 0 to 60min: (i) the
measured average concentration of soluble LDH collected in the
permeate, [P]LDH; (ii) the calculated average amount of soluble LDH
in the permeate based on the volume collected, PLDH; (iii) the
calculated average concentration of extracellular LDH remaining in
the retentate, R½ LDHEXT ; (iv) the calculated average concentration of
internal LDH in the retentate, R½ LDHINT ; (v) the calculated
proportion of intact cells remaining in the USD membrane
separation device, v.
Three main observations can be drawn from this data that
applies to the individual runs: (i) the concentration of soluble LDH
present in the permeate collected over the last minute of processing,
[P]LDH(tf), is in agreement with the concentrations of LDH
measured in the permeate stream during the last 10min of
operation; (ii) the highest concentrations of soluble LDH in the
Figure 3. Effect of processing time on themeasured transmission of LDH. The plot
shows the average of two repeats carried out under the same operating conditions
with two separately prepared cell suspensions (Q¼ 0.5 mLmin1, VR¼ 1.7 mL,
10,000 rpm, R½ TBTOT (0) 2.0 106 cells mL1). Dashed line shows the mean of T(tn)
values from 15 to 60 min. The table below shows the raw data for each of the four
separate experiments and both repeats.
Figure 4. Transmission values calculated at time ‘‘tf ’’ for 6,000 and 10,000 rpm
(emax 1.9 and 13.5WmL1, respectively), using measured concentration of soluble
LDH in the retentate (‘‘½RLDHEXT (60)’’) and the permeate (‘‘ P½ LDH tf
 
’’). Bars shown are
mean values 1 s.e. (j¼ 5; n¼ 4) and individual runs are shown as discrete points (•
6,000 and 410,000 rpm). Average transmission calculated at 6,000 rpm is 0.78 0.02
and 0.84 0.03 at 10,000 rpm. All experiments were carried out at a concentration of
2 106 total cells mL1. Note run 5 at 10,000 rpm is an outlier and, therefore, not taken
into account for average transmission value.
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permeate, [P]LDH, were measured during the ﬁrst 15min of
processing; (iii) the standard error for the concentration of
extracellular LDH in the retentate post-processing, R½ LDHEXT (60),
gives conﬁdence of the accuracy of this value as an estimate of the
population mean. The above considerations are relevant to gain
conﬁdence on the value for the transmission coefﬁcient, T(tf),
because T(tf) is heavily dependent on both [P]LDH(tf) and
R½ LDHEXT (60).
Results and Discussion
By performing a mass balance of the LDH in the system, the
proportion of intracellular LDH remaining in the USD membrane
separation device versus time can be monitored. RLDHINT (0) is the
calculated amount of intracellular LDH present in the USD
membrane separation device at the start of the experiment (i.e., in
the retentate at t¼ 0):
RLDHINT 0ð Þ ¼ RLDHTOT 0ð Þ  RLDHEXT 0ð Þ ð4Þ
where RLDHTOT (0) and RLDHEXT (0) are the measured total and
extracellular amounts of LDH present in the USD membrane
separation device at the start of the experiment, at t¼ 0min.
The following relationships depend on the assumption that the
total amount of LDH in the system (retentate and permeate) remains
constant throughout the duration of the membrane separation study.
For any particular interval, Dti, RLDHINT (Dti) is given by:
RLDHINT Dtið Þ ¼ RLDHINT 0ð Þ

Xi
i¼1 PLDH Dtið Þ þ RLDHEXT Dtið Þ
 
ð5Þ
where
Pi
i¼ 1PLDH(Dti) is the sum of the amounts of LDH recorded
in the permeate stream collected from the start of the experiment to
the end of interval Dti and RLDHEXT (Dti) is the calculated average
amount of extracellular LDH present in the retentate during interval
Dti.
The concentration RLDHEXT (Dti) is given by:
R½ LDHEXT Dtið Þ ¼
P½ LDH Dtið Þ
T tf
  ð6Þ
where [P]LDH(Dti) is the concentration of extracellular LDH
measured in the permeate collected over intervalDti and T(tf) is the
transmission of LDH as measured from the retentate and permeate
concentrations of LDH at the end of the experiment. Therefore, the
average amount of extracellular LDH present in the retentate over
interval Dti is given by:
R½ LDHEXT Dtið Þ ¼
P½ LDH Dtið Þ
T tf
   VP ð7Þ
where VP is the permeate volume over interval Dti (equal to
QDti). Hence from equations 5 and 7:
RLDHINT Dtið Þ ¼ RLDHINT 0ð Þ 
Xi
i¼1 PLDH Dtið Þ
 P½ LDH Dtið Þ
T tf
 
 !
 VP ð8Þ
Using Values Measured Experimentally, Equation 8 Becomes:
RLDHINT Dtið Þ ¼ RLDHINT 0ð Þ  VR

Xi
i¼1 P½ LDH Dtið Þ  Q Dti
 
 VP  P½ LDH Dtið Þ
T tf
 
 !
ð9Þ
where VR is the volume of the retentate chamber. Hence:
v Dtið Þ ¼
R½ LDHINT 0ð Þ  VR 
Pi
i¼1 P½ LDH Dtið Þ  Q Dti
  VP P½ LDH Dtið Þ
T tfð Þ
 
R½ LDHINT 0ð Þ  VR
ð10Þ
This parameter is calculated at 5-min intervals using the LDH
readings from the permeate. Therefore, to simplify equation 10, the
proportion of intracellular LDH (that of intact cells) remaining in
the USD membrane separation device, v, versus time can be
monitored and is given by:
v Dtið Þ ¼ RLDHINT Dtið ÞRLDHINT 0ð Þ
ð11Þ
Figure 5 is a stacked bar chart which shows the measured
amount of both total and extracellular LDH, as well as the calculated
intracellular LDH for each of (a) the feed, F; (b) control, C; and (c)
retentate post-processing, PP, at 6,000 and 10,000 rpm. The
cumulative amount of soluble LDH in the permeate stream, PLDH, is
also shown on the post-processing samples. Important information
may be acquired from the interpretation of this ﬁgure such as: (i)
there is no signiﬁcant difference in the total LDH present in the feed
and the non-sheared control held for 60min; (ii) there is good
agreement in the amount of total LDH in the feed and that after
processing. The ﬁrst observation is of relevance to show that LDH
was stable during the period of time measured and that the release
of LDH is due to the effect of processing conditions and not an
artifact of experimental procedure. These observations are in
agreement with previous studies carried out by Berger and Tietz
(1976) and Goldblum et al. (1990) and conﬁrm that there is no loss
of LDH activity by merely holding the sample without processing.
Goldblum et al. (1990) measured LDH activity in insect cells every
30min for 3 h showing no signiﬁcant changes during this period of
time. Moreover, Berger and Tietz (1976) reported LDH in serum to
be stable for at least 3 days at room temperature.
Overall, from the LDH data in Figure 5 it is evident that
processing at high disc speed for 60min results in an increased
amount of LDH measured in the permeate compared to low disc
speed. The next section addresses the results by analysis of cell
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damage with time of operation for each individual run as well as the
average of the ﬁve repeats at low and high disc speeds. It will also
include an analysis on the trends observed with the trypan blue
exclusion data.
The Impact of Disc Speed (Maximum Energy Dissipation
Rate) on Loss of Intact HCA2 Cells
Studies to evaluate the impact of disc speed on loss of intact cells
were carried out for low (6,000 rpm) and high (10,000 rpm) disc
speeds. These two speeds are equivalent to 1.9 and 13.5W
mL1maximum energy dissipation rates, respectively. The major
increase with greater speed is due to an enhanced axial ﬂow
circulation effects. The ﬂow characteristics in the USD device will
range from undeveloped laminar to turbulent ﬂow while at full scale
it would be expected that laminar conditions would prevail but with
regions of repeated exposure to high stress in pumps and entry and
exit locations. The USD device conditions chosen in this study
reﬂect the higher stress regions which may occur (McCoy et al.,
2010). Future work will require the match of USD conditions with
those existing in different full scale operations. Four performance
factors are used to characterize the effect on the cells of these disc
speeds; (i) the transmission of LDH calculated at tf; (ii) the
proportion of intact cells remaining as measured by LDH described
in the previous section in Eq 11; (iii) the change in the population of
viable cells; and (4) the change in percentage viability, both as
measured by trypan blue exclusion.
The transmission values for each individual run that were
previously shown in Figure 4, were used to calculate the amount of
LDH in the permeate over time and is shown in Figure 6 as a
proportion of the total amount of LDH measured. With the
exception of run #2 at low disc speed, reproducibility from one
repeat to another is high. Therefore, the average values (plotted as
continuous lines instead of discrete points on Fig. 6) are deemed to
be representative. Run #2 at low disc speed had an initial higher
concentration (4 106 cells mL1) than all the other runs,
approximately two times higher. This means the viscosity of the cell
suspension would be  three times higher (Zoro et al., 2009),
potentially leading to higher energy dissipation rates experienced
by the cells and the greater extent of cell damage measured. For the
purpose of this paper, this run is shown but not considered when
averaging the repeats.
Figure 7 shows the average values from Figure 6 of the four runs
at low disc speed and ﬁve runs at high speed, carried out to analyze
the impact of disc speed on cell damage as measured by LDH
release. Overall, observing these results in Figure 7, the proportion
of intracellular LDH remaining in the USD membrane separation
device throughout operation decreased 8% at a low disc speed
and 30% at a high disc speed. This ﬁnding suggests that
increasing the speed of the disc, causes more damage to the cellular
population being processed. Mass balances for both disc speeds
(Fig. 5) reveal that the amount of total LDH in the non-sheared
controls held at 21 1C in a centrifuge tube concurrently for the
duration of the experiment did not decrease. This leads to the
conclusion that the changes seen at the two disc speeds can be fully
attributed to processing conditions.
Moreover, when looking at the plots for the individual repeats
(Fig. 7), the data shows the same proﬁle of decrease with time. A
combination of ﬁrst order expressions could be used to describe
these proﬁles. For the ﬁrst 15–20min of processing, the rate of
damage to intact cells is faster than the remaining 40–45min of
processing. This indicates a fairly evident weaker population of cells
to start with, followed by amore robust remaining cell population. It
may be that if processing was prolonged, the second population
may continue to be progressively damaged until there are no cells
left in the USD membrane separation device. Previous studies on
Figure 5. Amount of LDH measured and predicted for the feed (‘‘F’’), control (‘‘C’’),
and post-processing (‘‘P’’) samples at 6,000 and 10,000 rpm disc speeds (emax 1.9 and
13.5WmL1, respectively). The bars represent the cumulative LDH measured in the
permeate stream ( ), the measured soluble or extracellular LDH (&) and the predicted
internal LDH ( ). The individual points (• 6,000 rpm and~ 10,000 rpm) represent the
total LDH (sum of permeate, extracellular and internal). All experiments were carried
out at a concentration of 2 106 total cells mL1. The control is a non-sheared
sample held in a centrifuge tube concurrently, 21 1ºC, for the duration of the
experiment. High disc speed resulted in an increased amount of LDH measured in the
permeate compared to low speed and, therefore, a decreased amount of predicted
internal LDH. Data shown are mean values 1 s.e. (6,000 rpm j¼ 4 and n¼ 4;
10,000 rpm j¼ 5 and n¼ 4).
Figure 6. Cumulative LDH in the permeate stream over total LDH versus time at
6,000 and 10,000 rpm disc speeds (emax 1.9 and 13.5WmL1, respectively). All
experiments were carried out at a concentration of2 106 total cells mL1 except for
run #2 at 6,000 rpm () which had a higher starting concentration of cells (4 106
cells mL1). Therefore, run #2 at 6,000 rpm is shown but not taken into account for best
fit. The control is a non-sheared sample held in a centrifuge tube concurrently,
21 1ºC, for the duration of the experiment as defined by Figure 2 part (c) and typically
showed no significant release of LDH over 60 min (data not shown).
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cell damage carried out by Midler and Finn (1966), observed that
the damage of protozoa cells in a uniform shear device showed a two
phase behavior; the ﬁrst phase being a rapid primary damage
followed by a slow decline of viable cells. They concluded that cell
damage may not only be related to magnitude of the hydrodynamic
forces but also to the exposure time. From our study, this may be the
case but it is not a straightforward and certain observation to test
due to the number of complications that this implies. Prolonged
processing time may cause cell damage by the introduction of other
variables such as cell ageing while processing or change in the
processing medium properties due to release of intracellular
components.
Figure 8 was used to analyze the impact of disc speed on cell
damage as measured by trypan blue exclusion. It shows the
percentage viability for the feed, control and post-processing
samples and both disc speeds. After harvesting the cells and prior to
processing, high percentage viabilities are observed (97.3% as
shown by the feed samples). These high percentages are maintained
when the cells are held at 21 1C in a centrifuge tube concurrently
for the duration of the experiment (97.1% as shown by the control
samples). Further analysis of Figure 8 shows that high disc speed
resulted in a signiﬁcant 10% (P¼ 0.001) drop in percentage
viability post-processing compared to no drop in percentage
viability at a low disc speed.
The legend for Figure 8 shows a table with the concentration of
total and viable cells for the same three samples. The average
concentrations of viable cells in the control samples are 1.97 0.20
and 2.06 0.09 106 cells mL1 for low and high disc speeds
respectively. At high disc speed there is a signiﬁcant 25%
(P¼ 0.003) decrease in the population of viable cells, compared to
no decrease at a low disc speed.
Overall, the comparison of the performance factors of the feed
samples to the controls, showed that holding the cells at 21 1C in
a centrifuge tube concurrently for the duration of the experiment
did not lead to spontaneous release of LDH or drop in percentage
viability. Moreover, with respect to cell damage, LDH release
showed similar trends and amounts of damage for both low and
high disc speed as trypan blue exclusion method.
The Impact of Disc Speed (emax) on Morphology of HCA2
Cells in Suspension
It has been widely reported that changes in physical appearance and
morphology can occur after the cells are exposed to stresses (Al-
Rubeai et al., 1995a; Kretzmer and Sch€ugerl, 1991) and can serve as
indicators of the state of cell health (Agashi et al., 2009; Kretzmer
and Sch€ugerl, 1991). Within this section, the morphology and
physical appearance of cells post-processing was investigated.
Morphological analysis was carried out on the cellular suspension
immediately post-processing and 2 h post-processing.
Figure 9 shows some examples of the type of images obtained
from the automated haemocytometer. For both low and high disc
speeds (Fig. 9(1) and (2), respectively) three time points are shown;
feed samples (labeled A), immediately post-processing (labeled B)
and 2 h hold post-processing (labeled C), all at 21 1C.
From Figures 9(1A) and (2A), feed samples for both low and high
disc speeds, it can be seen that most cells are round viable cells with
sharply deﬁned outer edges or clearly non-viable as stained positive
for trypan blue exclusion. However, the appearance of elongated and
“blebby” cells is observed immediately post-processing (Fig. 9(1B)
and 9(2B)). Because “blebbing” can be a characteristic of cell death,
preliminary analysis ofmeasurement of programmed cell death (data
not shown) using Caspase3—a key molecule in the apoptotic
Figure 7. Membrane processing of feed (0 h cell ageing) HCA2 cells—effect of
disc speed on cell damage as recorded by release of LDH (data averaged from Fig. 6). A
non-sheared control held in a centrifuge tube concurrently, 21 1ºC, for the duration of
the experiment was used to measure LDH pre and post-processing. This figure shows
the proportion of intracellular LDH remaining (ɷ, Eq 11), for 6,000 rpm () and 10,000 rpm
(~) at a concentration of 2 106 total cells mL1 (emax 1.9 and 13.5WmL1,
respectively). High disc speed resulted in a 30% reduction of viable cells as
measured by release of LDH. Data shown are mean values 1 s.e. (6,000 rpm j¼ 4 and
n¼ 4; 10,000 rpm j¼ 5 and n¼ 4).
Figure 8. Membrane processing of feed (0 h cell ageing) HCA2 cells—effect of
disc speed on percentage viability of the cellular suspension as recorded by trypan
blue exclusion. A non-sheared control held in a centrifuge tube concurrently, 21 1ºC,
for the duration of the experiment was used to measure trypan blue exclusion pre- and
post-processing for both 6,000 and 10,000 rpm (emax 1.9 and 13.5WmL1,
respectively). Trypan blue exclusion indicates that processing at high disc speed,
resulted in a10% drop in percentage viability post-membrane processing. Low drop
was observed in percentage viability at a low disc speed. Significant changes between
non-sheared control and post-processing (	P< 0.5, 		P< 0.01, 			P< 0.001).
Table below shows mean of raw data determined by trypan blue exclusion for
concentration of total and viable cells. Processing at high disc speed, resulted in a
25% reduction of viable cells. Data shown are mean values 1 s.d. (6,000 rpm j¼ 4
and n¼ 4; 10,000 rpm j¼ 5 and n¼ 4).
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mechanism and induction of apoptosis (Darzynkiewicz and
Pozarowski, 2007; Smolewski et al., 2002)—was carried out and
indicated increased activity post-processing. “Blebs” are membrane
bound protrusions from the plasma membrane caused by weakness
in the actin cytoskeleton which helps maintain cellular structure
(Kumar et al., 2007). Therefore, the potential of these being “blebs”
would need to be studied further using f-actin stain. Literature
reveals that “blebbing” is a dynamic process and can resolve itself
once the actin cytoskeleton is restored (Kumar et al., 2007) and in
fact, images C, after 2 h hold post-processing, reveal that a large
portion of the “blebs” have disappeared and there are lower numbers
of elongated cells. This trend seems to be more evident at high disc
speed (Fig. 9(2)) than at low disc speed (Fig. 9(1)).
These morphological characteristics identiﬁed were used as
building blocks to deﬁne the different cell types to develop a
script for image processing using MATLAB Image Processing
Toolbox (MathWorks, Cambridge, UK). Figure 9D shows some
examples for each of the cell types. The cells were classiﬁed into
short elongated (SE), long elongated (LE), viable round (VR),
non-viable (NV), and debris (DEBRIS). For example, parameters
such as aspect ratio were used to classify cells into round, short or
long elongated cells; intensity was used to identify dead and alive
and area was used to identify debris from cells. Originally, a
degree of “blebbing” for each cell type was going to be included
as an added characteristic to each cell population. However, the
implementation and incorporation of this parameter proved to be
Figure 9. Images of (A) feed; (B) post-processing, and (C) 2 h hold post-processing at low (1) and high (2) disc speeds (6,000 and 10,000 rpm, respectively). Figure (D) shows
examples of HCA2 images from the cell image library created to facilitate the identification of cell phenotype in a given image. The cell library was constructed from images selected
for each designated category. Each category was assigned parameters (such as aspect ratio and intensity) and these were then used as rules for identification purposes for the
Matlab script.
Masri et al.: Scale Down of Membrane Recovery of Cells for Therapy 1249
Biotechnology and Bioengineering
unreliable. The images from the automated haemocytometer were
analyzed using the Matlab script and the proportions for each of
the cell populations at the three given time points (feed,
immediately post-processing and 2 h hold post-processing) are
shown in Figure 10A and B (low and high disc speeds
respectively).
From Figure 10B, high disc speed, it can be seen that there is
an increase in the proportion of dead cells and a reduction in the
proportion of viable round cells immediately post-processing
that remained the same after 2 h hold. For both low and high
disc speeds (Fig. 10A and B, respectively) there is an increase in
the proportion of both short and long elongated cells
immediately post-processing that appears to return to feed
sample levels after the 2 h hold. The apparent trend previously
appreciated in Figure 9 is in agreement with the quantitative data
in Figure 10.
A temporary change of morphology is appreciated by the
appearance of elongated and blebby cells post-processing, most of
which appear to resolve themselves after 2 h of hold. This is not
to say that categorizing the state of cell health on physical
appearance alone would be sufﬁcient, nonetheless it may serve as
a fast and inexpensive way of preliminary assessment of cell
health.
Conclusion
The focus of this study was a clinically relevant human ﬁbroblast
(mesenchymal) cell line. Tests with cell lines such as human
mesenchymal stem cells (hMSCs) would be key to establish a
broader relationship for the prediction of full scale processing. The
greater heterogeneity compared with the mesenchymal cells used
here, might lead to different relations between loss of cell
membrane integrity and processing conditions. Furthermore, a
wider range of cell characterizations assays (e.g., immunocyto-
chemistry, ﬂow cytometry, cell proliferation) would be needed,
especially when conditions are established of no loss of cell
membrane integrity. Studies at both higher (applicable to
concentration operations) and lower (applicable for example to
the initial harvest of hMSCs) concentrations, will probably lead to
different sensitivities to the imposed shear conditions.
A methodology to assess cell damage as measured by LDH
release into the permeate of the USD membrane separation device
was developed, tested and supported by trypan blue exclusion
results. Investigation of the impact of disc speed on cell damage
conﬁrmed that the decrease in the proportion of intracellular LDH
remaining in the USD membrane separation device throughout
processing was higher at high disc speed than at low disc (30%
compared to 8%). Trypan blue exclusion method also revealed a
higher decrease in the population of viable cells at high disc speed
than at low disc speed (25% compared to no drop). Moreover,
high disc speed resulted in a signiﬁcant drop of 10% in viability
post-processing compared to no drop at a low disc speed as
measured by trypan blue exclusion. It appears that LDH release may
be a more sensitive indicator of earlier damage to the cell membrane
than trypan blue exclusion, observation which has been previously
documented by Lappalainen et al. (1994). Lastly, morphological
analysis of cells in suspension revealed the appearance of elongated
and “blebby” cells immediately post-processing, most of which
disappear after a 2 h hold; trend which was more apparent when
operating at high disc speed than at low disc speed.
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Nomenclature
A soluble LDH present (mU)
C control
F feed
i interval number
j number of runs
n number of measurements
P permeate
Pw power (W)
PP post-processing
Q flow rate (mLmin1)
R retentate
t time (min)
T transmission
V volume (mL)
Figure 10. Effect of disc speed (A) 6,000 rpm and (B) 10,000 rpm on cell
morphology after shear and after shear plus hold, quantified by software for image
processing developed using Matlab Image Processing Toolbox (MathWorks, Cam-
bridge, UK) in the Biochemical Engineering Department (UCL). The cell categories
correspond to libraries created for the Matlab script (Fig. 9D). The proportion of each
cell type or population was compared to the total cells in the sample for feed (&),
immediately post-processing ( ), and 2 h hold post-processing ( ).
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Symbols
[] concentration (cells mL1 or mU mL1)
D changeP
sum
emax maximum energy dissipation rate, PW/V (WmL
1)
ɷ proportion of intracellular LDH remaining
g shear rate (s1)
r density (kg m3)
y kinematic viscosity (m2 s1)
m viscosity (mPa s)
Subscripts and Superscripts
EXT external
f final
INT internal
LDH lactate dehydrogenase
TB trypan blue
TOT total
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